Clearpoint Neuro Inc expected to post a loss of 16 cents a share - Earnings Preview

Clearpoint Neuro

09/05/2025 22:31

Clearpoint Neuro Inc CLPT.OQ CLPT.O is expected to show a rise in quarterly revenue when it reports  results on May 13 for the period ending March 31 2025

The Solana Beach California-based  company is expected to report a 7.3% increase in revenue to $8.2 million from $7.64 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Clearpoint Neuro Inc is for a loss of 16 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Clearpoint Neuro Inc is $28.00​, above​ its last closing price of $14.25. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.19
-0.16
-0.20
Missed
-22.5
Sep. 30 2024
-0.19
-0.17
-0.18
Missed
-3.8
Jun. 30 2024
-0.19
-0.20
-0.16
Beat
18.6​
Mar. 31 2024
-0.18
-0.19
-0.16
Beat
15.8
​​Dec. 31 2023
-0.18
-0.20
-0.19
Beat
6.6
Sep. 30 2023
-0.25
-0.25
-0.20
Beat
20​
Jun. 30 2023
-0.19
-0.19
-0.29
Missed
-52.6
Mar. 31 2023
-0.18
-0.18
-0.23
Missed
-24.3

This summary was machine generated May 9 at 21:31 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)